PharmaBlock Sciences (Nanjing), Inc.

SZSE:300725 Stock Report

Market Cap: CN¥6.9b

PharmaBlock Sciences (Nanjing) Balance Sheet Health

Financial Health criteria checks 4/6

PharmaBlock Sciences (Nanjing) has a total shareholder equity of CN¥2.9B and total debt of CN¥1.4B, which brings its debt-to-equity ratio to 48.1%. Its total assets and total liabilities are CN¥4.7B and CN¥1.9B respectively. PharmaBlock Sciences (Nanjing)'s EBIT is CN¥217.5M making its interest coverage ratio 5.6. It has cash and short-term investments of CN¥1.2B.

Key information

48.1%

Debt to equity ratio

CN¥1.38b

Debt

Interest coverage ratio5.6x
CashCN¥1.24b
EquityCN¥2.87b
Total liabilitiesCN¥1.86b
Total assetsCN¥4.73b

Recent financial health updates

Recent updates

PharmaBlock Sciences (Nanjing), Inc.'s (SZSE:300725) P/E Is Still On The Mark Following 40% Share Price Bounce

Sep 30
PharmaBlock Sciences (Nanjing), Inc.'s (SZSE:300725) P/E Is Still On The Mark Following 40% Share Price Bounce

PharmaBlock Sciences (Nanjing)'s (SZSE:300725) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Aug 23
PharmaBlock Sciences (Nanjing)'s (SZSE:300725) Sluggish Earnings Might Be Just The Beginning Of Its Problems

We Think PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Taking Some Risk With Its Debt

Jul 31
We Think PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Taking Some Risk With Its Debt

PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Increasing Its Dividend To CN¥0.31

Jun 12
PharmaBlock Sciences (Nanjing) (SZSE:300725) Is Increasing Its Dividend To CN¥0.31

PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Apr 21
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Looks Just Right With A 25% Price Jump

Mar 07
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) Looks Just Right With A 25% Price Jump

Financial Position Analysis

Short Term Liabilities: 300725's short term assets (CN¥2.5B) exceed its short term liabilities (CN¥609.7M).

Long Term Liabilities: 300725's short term assets (CN¥2.5B) exceed its long term liabilities (CN¥1.2B).


Debt to Equity History and Analysis

Debt Level: 300725's net debt to equity ratio (5%) is considered satisfactory.

Reducing Debt: 300725's debt to equity ratio has increased from 13.2% to 48.1% over the past 5 years.

Debt Coverage: 300725's debt is not well covered by operating cash flow (19.6%).

Interest Coverage: 300725's interest payments on its debt are well covered by EBIT (5.6x coverage).


Balance Sheet


Discover healthy companies